• DHEA as a Mechanistic Probe in Ovarian Research

  2026-08-13

  Explore how Dehydroepiandrosterone (DHEA) can be used to dissect immune–granulosa cell interactions, apoptosis, and ovarian dysfunction. This article translates recent CD163 findings into practical assay-design decisions while also defining the limits of DHEA-based neuroprotection and PCOS models.

• ARCA EGFP mRNA for Transfection Workflows

  2026-08-13

  ARCA EGFP mRNA provides a direct fluorescence readout for separating delivery failure from downstream expression problems in mammalian cells. Its ARCA cap and optimized poly(A) tail support reproducible mRNA transfection control, including early-stage optimization of lipid and nanoparticle delivery systems.

• Praeruptorin A: Workflows for Metastasis Research

  2026-08-12

  Praeruptorin A supports mechanism-first workflows that separate anti-metastatic activity from general cytotoxicity. This guide translates ERK/MMP1 evidence into practical HCC assays while showing how carefully bounded extensions can support ferroptosis, intestinal barrier, and cardiomyopathy research.

• UTP Solution (100 mM) for RNA Assays

  2026-08-12

  Explore how UTP Solution and Uridine-5'-triphosphate trisodium salt support reproducible RNA assays while clarifying what nucleotide quality can—and cannot—reveal about TRIM66-dependent olfactory receptor regulation.

• Anti-HMGB1 Rabbit Monoclonal Antibody Guide

  2026-08-11

  This guide explains how to use Anti-HMGB1 Rabbit Monoclonal Antibody MA3057 for HMGB1 detection in human, mouse, and rat samples by Western blot, immunohistochemistry, and flow cytometry. It is intended for controlled research workflows only; no directly matched paper evidence or diagnostic, therapeutic, or medical-use validation is supplied.

• Novel Allosteric PDK4 Inhibitors in Metabolic Disease

  2026-08-11

  The 2019 Journal of Medicinal Chemistry study identified anthraquinone-derived allosteric pyruvate dehydrogenase kinase 4 inhibitors, with compound 8c showing an in vitro IC50 of 84 nM. Its metabolic stability, pharmacokinetic behavior, and activity in diet-induced obesity, allergy, and cancer-related models support further investigation of PDK4-directed PDH activation, while remaining preclinical evidence.

• BMS 599626: EGFR/HER2 to Senescence

  2026-08-10

  A translational framework for using BMS 599626 dihydrochloride to interrogate EGFR/HER2 signaling, cancer cell proliferation, xenograft response, and carefully defined links to senescence research.

• Metal-Chelating L-Phe Nanostructures Reprogram Tumor Immunit

  2026-08-09

  A 2024 Nature Nanotechnology study shows that Mg2+-, Fe2+-, or Zn2+-chelating L-phenylalanine nanostructures can activate dendritic cells by coupling ion-channel regulation to NF-κB and NLRP3 signaling. When combined with short-term starvation, this approach remodels the immunosuppressive tumor microenvironment and improves breast-tumor sensitivity to immune checkpoint blockade.

• Wnt–EGFR Control of DNA Damage Responses in Drosophila

  2026-08-08

  Ewen-Campen and Perrimon developed an in vivo genetic system to induce reproducible DNA double-strand damage in the Drosophila wing imaginal disc and used it to define a Wg–Rhomboid–EGFR survival circuit. Their results show that canonical Wnt signaling can alter the apoptotic consequence of DNA damage through Chk2-, p53-, and E2F1-dependent mechanisms, offering a framework for studying tissue-specific damage sensitivity.

• Trelagliptin Protects Chondrocytes via AMPK/SOX-9

  2026-08-07

  The reference study identifies Trelagliptin as a protective modulator of IL-1β-injured human chondrocytes, linking its effects to restoration of AMPK activity and SOX-9 expression. Its findings extend investigation of this diabetes drug beyond glucose control while also defining important limits for translation to osteoarthritis models.

• Poly(I:C): Synthetic dsRNA Analog and Benchmark TLR3 Agonist

  2026-08-07

  Poly(I:C), a synthetic double-stranded RNA analog, is a potent TLR3 agonist and interferon inducer widely used in immunology research. It robustly stimulates dendritic cell maturation and innate immune responses, serving as a gold-standard tool for modeling antiviral immunity.

• Pterostilbene Enhances Mitophagy to Delay Dermal Fibroblast

  2026-08-06

  Zhou et al. (2025) demonstrate that pterostilbene counters cellular aging in human dermal fibroblasts by restoring mitochondrial quality through the promotion of mitophagy. This mechanistic insight highlights a promising strategy for mitigating both intrinsic and extrinsic skin aging at the cellular level.

• PCMT1 Drives Ovarian Cancer Metastasis via Anoikis Resistanc

  2026-08-06

  Zhang et al. employed a genome-wide CRISPR/Cas9 knockout screen to systematically uncover PCMT1 as a critical regulator of anoikis resistance and metastasis in ovarian cancer. Their findings reveal a mechanistic link between PCMT1, ECM remodeling, and integrin-FAK-Src signaling, highlighting new therapeutic avenues and experimental models for metastatic disease.

• Triazole ALDH2 Activators: New Frontiers in Myocardial Prote

  2026-08-05

  This article reviews the innovation and mechanistic findings of a recent study on novel triazole-based aldehyde dehydrogenase 2 (ALDH2) activators for myocardial ischemia-reperfusion injury. The study demonstrates that these small molecules, especially compound Z17, significantly enhance ALDH2 activity and confer robust cardioprotection in preclinical models, addressing a critical gap in myocardial infarction therapeutics.

• Taltirelin Acetate: Translational Mechanisms and Next-Genera

  2026-08-05

  Explore the unique neuroprotective mechanisms of Taltirelin acetate, a long-acting TRH analog, with cutting-edge insights into its role in Parkinson’s disease research and beyond. This in-depth article unlocks new translational directions and protocol innovations for preclinical neuroscience.

15794 records 1/1053 page Next 12345 下5页 Last page